Momenta Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals Industries Ltd. et al

Filing 111

Judge Nathaniel M. Gorton: ORDER entered granting 109 Motion for Clarification re 108 Memorandum & ORDER (Patch, Christine)

United States District Court
District of Massachusetts
________________________________
)
MOMENTA PHARMACEUTICALS, INC.,
)
SANDOZ INC.,
)
Plaintiffs,
)
)
Civil Action No.
v.
)
11-11681-NMG
)
AMPHASTAR PHARMACEUTICALS, INC., )
INTERNATIONAL MEDICATION
)
SYSTEMS, LTD., WATSON
)
PHARMACEUTICALS, INC., WATSON
)
PHARMA, INC.
)
Defendants.
)
________________________________ )
)
MOMENTA PHARMACEUTICALS, INC.
)
and SANDOZ INC.,
)
Plaintiffs,
)
)
Civil Action No.
v.
)
10-12079-NMG
)
TEVA PHARMACEUTICALS USA, INC., )
Defendants.
)
________________________________ )
ORDER
GORTON, J.
Plaintiffs’ motion for clarification or modification of the
order on claim construction (Docket No. 292 in the Amphastar
action, and Docket No. 109 in the Teva action) is ALLOWED.

As

plaintiffs suggest, the Court intended to define the term
“structural signature” according to the first part of the
definition offered in the specification of the ’886 patent.

The

omission of “e.g.” in the definition listed in the Order portion

-1-

of the Memorandum and Order was inadvertent.

Thus, “a structural

signature” means
information regarding, e.g., the identity, number and
physiochemical properties of the mono- and di-saccharide
building blocks of a polysaccharide.
So ordered.
/s/ Nathaniel M. Gorton
Nathaniel M. Gorton
United States District Judge
Dated July 31, 2012

-2-